Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib

Author： Tetsumoto Satoshi  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.17, Iss.2, 2012-04, pp. : 155-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

By Clarke Jennifer   Pao William   Wu Nian   Miller Vincent   Lassman Andrew  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 283-286

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Leptomeningeal metastases from solid malignancy: a review

By Taillibert Sophie   Laigle-Donadey Florence   Chodkiewicz Catherine   Sanson Marc   Hoang-Xuan Khê   Delattre Jean-Yves  

Journal of Neuro-Oncology, Vol. 75, Iss. 1, 2005-10 ,pp. : 85-99

Springer Publishing Company

Access to resources Recommend Favorite

Spinal Leptomeningeal Metastases from Prostate Cancer

By Deinsberger R.   Regatschnig R.   Kaiser B.   Bankl H.  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 293-297

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice

By Zerbe Laura  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 605-620

Springer Publishing Company

Access to resources Recommend Favorite